IFI204 Gene

IFI204 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IFI204 Gene</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Microglia](/cell-types/microglia-neuroinflammation)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Neurons](/entities/neurons)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Brain endothelial cells</td>
<td>Low</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Ifi204 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

IFI204 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IFI204 Gene</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Microglia](/cell-types/microglia-neuroinflammation)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Neurons](/entities/neurons)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Brain endothelial cells</td>
<td>Low</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Ifi204 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

IFI204 (Interferon Alpha Inducible Protein 204), also known as AIM2 (Absence in Melanoma 2) or PYHIN1, is a member of the AIM2-like receptor (ALR) family of proteins. This gene encodes a cytosolic DNA sensor that plays a critical role in innate immunity and inflammasome activation. While traditionally studied in the context of cancer and autoimmune diseases, emerging research reveals important functions in the central nervous system, particularly in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD). [@choubey2010]

Gene Structure and Protein Architecture

The IFI204 gene spans approximately 21 kb on chromosome 1q23.1 and consists of 8 exons encoding a protein of 414 amino acids with a molecular weight of approximately 46 kDa. The protein structure comprises two key functional domains:

Pyrin Domain (PYD)

HIN-200 Domain

Molecular Functions

DNA Sensing and Inflammasome Activation

IFI204 functions as a canonical cytosolic DNA sensor. Upon binding to foreign or host-derived DNA in the cytosol:

Type I Interferon Response

IFI204 can also induce type I interferon (IFN-α/β) production through activation of the STING-TBK1-IRF3 pathway, though this function is more prominent for related family member IFI16.

Interactome

Key protein interactions include:

• ASC (PYCARD): Adapter for inflammasome assembly
• Caspase-1 (CASP1): Effector protease
• AIM2: Can form heterodimers
• IFI16: Related family member
• STING (TMEM173): Upstream activator

Expression in the Brain

Cellular Distribution

In the central nervous system, IFI204 shows a distinctive expression pattern:

Regulation of Expression

IFI204 expression is tightly regulated by:

• Type I interferons (IFN-α, IFN-β): Strong upregulation
• Type II interferon (IFN-γ): Moderate induction
• TNF-α: Synergistic with interferons
• Aging: Increased expression in aged brain
• Pathological stimuli: Aβ, [α-synuclein](/proteins/alpha-synuclein), [TDP-43](/mechanisms/tdp-43-proteinopathy)

Role in Alzheimer's Disease

Inflammasome Activation

The AIM2 inflammasome is significantly activated in AD brain tissue:

• AIM2/IFI204 protein levels are elevated in prefrontal [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus) of AD patients
• Colocalization with [amyloid-beta](/proteins/amyloid-beta) plaques suggests ongoing inflammasome activation
• Active caspase-1 and ASC specks are abundant in AD microglia

Molecular Mechanisms

Therapeutic Implications

• Small molecule inhibitors: AIM2 inflammasome inhibitors are in development
• Targeting IL-1β: Anti-IL-1β therapies may benefit AD patients
• DNA damage repair: Enhancing neuronal DNA repair may reduce IFI204 activation

Role in Parkinson's Disease

Substantia Nigra Involvement

Elevated IFI204/AIM2 expression has been observed in:

• Substantia nigra pars compacta of PD patients
• Microglia surrounding dopaminergic neurons
• Lewy bodies (colocalization with α-synuclein)

Mechanisms

• α-Synuclein-induced inflammation: α-synuclein aggregates can activate IFI204 inflammasome
• Mitochondrial DNA: Damaged mitochondria release mtDNA that activates cytosolic DNA sensors
• Microglial activation: Chronic inflammation drives dopaminergic neuron loss

Role in ALS and FTD

TDP-43 Pathology

IFI204 is activated in ALS and FTD with TDP-43 pathology:

• TDP-43 aggregation may disrupt normal DNA handling in neurons
• Neuronal DNA damage triggers IFI204 inflammasome
• Motor neurons show particular vulnerability

C9orf72 Connection

The [C9orf72](/entities/c9orf72) repeat expansion, the most common genetic cause of ALS/FTD, may intersect with IFI204 pathways through:

• Dysregulated [autophagy](/entities/autophagy) leading to DNA accumulation
• Altered innate immune responses

Research Methods

Detection in Brain Tissue

• Immunohistochemistry: Antibody detection in fixed brain sections
• Western blot: Protein level quantification
• qPCR: mRNA expression analysis
• ELISA: Cytokine (IL-1β, IL-18) measurement

Functional Studies

• In vitro inflammasome assays: ASC speck formation
• Primary neuron/microglia cultures: Mechanism studies
• CRISPR-Cas9: Genetic manipulation
• Animal models: Transgenic and knock-in models

Biomarker Potential

• CSF IFI204: Under investigation as a biomarker
• Blood inflammatory markers: Correlates with disease progression

Therapeutic Targeting

Drug Development

Several approaches are being explored:

Repurposing Opportunities

Existing drugs with potential:

• Colchicine: Anti-inflammatory, microtubule effects
• Anakinra: IL-1 receptor antagonist
• Canakinumab: Anti-IL-1β antibody

Summary

IFI204/AIM2 represents a critical link between DNA sensing, innate immunity, and neurodegenerative disease pathogenesis. While primarily characterized in peripheral immune cells, emerging evidence demonstrates important functions in brain cells, particularly microglia. The inflammasome activation driven by IFI204 contributes to chronic neuroinflammation in AD, PD, ALS, and FTD. Targeting this pathway offers therapeutic potential, though challenges remain in achieving brain penetration and achieving selective modulation.

See Also

• [Neurodegeneration](/diseases/neurodegeneration) — General mechanisms

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

Overview

Ifi204 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Ifi204 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

• [Allen Human Brain Atlas - IFO204](https://human.brain-map.org/microarray/search/show?search_term=IFO204)
• [Allen Cell Type Atlas - ifo204](https://celltypes.brain-map.org/)
• [Allen Mouse Brain Atlas - ifo204](https://mouse.brain-map.org/)

References